India exempts anti-malarial drugs and diagnostics from excise duty until Oct 1, 2015, aiding national malaria control efforts.

The Government of India, through the Ministry of Finance, issued a notification exempting certain goods from excise duty to support the Intensified Malaria Control Project (IMCP)-II under the National Vector Borne Disease Control Programme. This exemption applies to anti-malarial drugs such as Artemisinin-based Combination Therapy and Artesunate Injection Kits, as well as diagnostics and medical products like Bivalent Rapid Diagnostic Test Kits and Long Lasting Insecticidal Nets. The exemption is valid until October 1, 2015, contingent upon verification by a designated government official confirming the goods' intended use for the IMCP, funded by the Global Fund.

---

---

---